WO2013114300A1 - Revêtements acryliques modifiés actifs permettant d'obtenir une résistance améliorée de membranes d'osmose inverse à l'encrassement biologique - Google Patents
Revêtements acryliques modifiés actifs permettant d'obtenir une résistance améliorée de membranes d'osmose inverse à l'encrassement biologique Download PDFInfo
- Publication number
- WO2013114300A1 WO2013114300A1 PCT/IB2013/050794 IB2013050794W WO2013114300A1 WO 2013114300 A1 WO2013114300 A1 WO 2013114300A1 IB 2013050794 W IB2013050794 W IB 2013050794W WO 2013114300 A1 WO2013114300 A1 WO 2013114300A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methacrylate
- thin
- glycidyl
- hydroxyl
- film composite
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 86
- 238000000576 coating method Methods 0.000 title claims description 37
- 238000001223 reverse osmosis Methods 0.000 title claims description 22
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 title description 3
- 229920000642 polymer Polymers 0.000 claims abstract description 27
- 239000002131 composite material Substances 0.000 claims abstract description 25
- 239000010409 thin film Substances 0.000 claims abstract description 23
- 239000000758 substrate Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 19
- 230000003373 anti-fouling effect Effects 0.000 claims abstract description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 32
- 239000011248 coating agent Substances 0.000 claims description 30
- -1 polypropylene Polymers 0.000 claims description 28
- 150000001412 amines Chemical class 0.000 claims description 20
- 229920000058 polyacrylate Polymers 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 14
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 claims description 13
- 239000004952 Polyamide Substances 0.000 claims description 11
- 229920002647 polyamide Polymers 0.000 claims description 11
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 claims description 9
- 239000003139 biocide Substances 0.000 claims description 8
- 239000010410 layer Substances 0.000 claims description 8
- 239000011247 coating layer Substances 0.000 claims description 7
- 229920002492 poly(sulfone) Polymers 0.000 claims description 7
- 239000010408 film Substances 0.000 claims description 6
- 229920000728 polyester Polymers 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 239000012620 biological material Substances 0.000 claims description 4
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 239000004695 Polyether sulfone Substances 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 3
- 229920000515 polycarbonate Polymers 0.000 claims description 3
- 239000004417 polycarbonate Substances 0.000 claims description 3
- 229920006393 polyether sulfone Polymers 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 20
- 150000001875 compounds Chemical class 0.000 abstract description 13
- 238000002360 preparation method Methods 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 239000008199 coating composition Substances 0.000 abstract description 3
- 238000007306 functionalization reaction Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 3
- 230000000975 bioactive effect Effects 0.000 abstract description 2
- 238000011109 contamination Methods 0.000 abstract description 2
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 239000001257 hydrogen Substances 0.000 description 25
- 229910052739 hydrogen Inorganic materials 0.000 description 25
- 239000000178 monomer Substances 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 15
- 125000003118 aryl group Chemical group 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000002202 Polyethylene glycol Substances 0.000 description 11
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical class OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 description 11
- 229920001223 polyethylene glycol Polymers 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- 230000004907 flux Effects 0.000 description 10
- 150000002431 hydrogen Chemical class 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 229940063557 methacrylate Drugs 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- 229910052709 silver Inorganic materials 0.000 description 7
- 239000004332 silver Substances 0.000 description 7
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 6
- 239000004971 Cross linker Substances 0.000 description 6
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 229910052736 halogen Inorganic materials 0.000 description 6
- 150000002367 halogens Chemical class 0.000 description 6
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 6
- LMEWRZSPCQHBOB-UHFFFAOYSA-M silver;2-hydroxypropanoate Chemical compound [Ag+].CC(O)C([O-])=O LMEWRZSPCQHBOB-UHFFFAOYSA-M 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000005227 gel permeation chromatography Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 229920005862 polyol Polymers 0.000 description 5
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- 125000003368 amide group Chemical group 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 229940113088 dimethylacetamide Drugs 0.000 description 4
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 4
- 125000005641 methacryl group Chemical group 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- NPSSWQJHYLDCNV-UHFFFAOYSA-N prop-2-enoic acid;hydrochloride Chemical compound Cl.OC(=O)C=C NPSSWQJHYLDCNV-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- 238000012695 Interfacial polymerization Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000001361 adipic acid Substances 0.000 description 3
- 235000011037 adipic acid Nutrition 0.000 description 3
- 230000000181 anti-adherent effect Effects 0.000 description 3
- 125000000732 arylene group Chemical group 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229940052303 ethers for general anesthesia Drugs 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- ABMFBCRYHDZLRD-UHFFFAOYSA-N naphthalene-1,4-dicarboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1 ABMFBCRYHDZLRD-UHFFFAOYSA-N 0.000 description 3
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- NZSHDTMWQRNGIA-UHFFFAOYSA-N 2-[2-[2-(2-oxo-2-phenylacetyl)oxyethoxy]ethoxy]ethyl 2-oxo-2-phenylacetate Chemical compound C=1C=CC=CC=1C(=O)C(=O)OCCOCCOCCOC(=O)C(=O)C1=CC=CC=C1 NZSHDTMWQRNGIA-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241001156739 Actinobacteria <phylum> Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920002292 Nylon 6 Polymers 0.000 description 2
- 229920002302 Nylon 6,6 Polymers 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical compound CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 241000192142 Proteobacteria Species 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 238000003848 UV Light-Curing Methods 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000032770 biofilm formation Effects 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical group NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 229920001903 high density polyethylene Polymers 0.000 description 2
- 239000004700 high-density polyethylene Substances 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- 125000000686 lactone group Chemical group 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- NCNYEGJDGNOYJX-NSCUHMNNSA-N (e)-2,3-dibromo-4-oxobut-2-enoic acid Chemical compound OC(=O)C(\Br)=C(/Br)C=O NCNYEGJDGNOYJX-NSCUHMNNSA-N 0.000 description 1
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- GIMQKKFOOYOQGB-UHFFFAOYSA-N 2,2-diethoxy-1,2-diphenylethanone Chemical class C=1C=CC=CC=1C(OCC)(OCC)C(=O)C1=CC=CC=C1 GIMQKKFOOYOQGB-UHFFFAOYSA-N 0.000 description 1
- PIZHFBODNLEQBL-UHFFFAOYSA-N 2,2-diethoxy-1-phenylethanone Chemical class CCOC(OCC)C(=O)C1=CC=CC=C1 PIZHFBODNLEQBL-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- FIOCEWASVZHBTK-UHFFFAOYSA-N 2-[2-(2-oxo-2-phenylacetyl)oxyethoxy]ethyl 2-oxo-2-phenylacetate Chemical compound C=1C=CC=CC=1C(=O)C(=O)OCCOCCOC(=O)C(=O)C1=CC=CC=C1 FIOCEWASVZHBTK-UHFFFAOYSA-N 0.000 description 1
- UHFFVFAKEGKNAQ-UHFFFAOYSA-N 2-benzyl-2-(dimethylamino)-1-(4-morpholin-4-ylphenyl)butan-1-one Chemical compound C=1C=C(N2CCOCC2)C=CC=1C(=O)C(CC)(N(C)C)CC1=CC=CC=C1 UHFFVFAKEGKNAQ-UHFFFAOYSA-N 0.000 description 1
- KMNCBSZOIQAUFX-UHFFFAOYSA-N 2-ethoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OCC)C(=O)C1=CC=CC=C1 KMNCBSZOIQAUFX-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- 229940093475 2-ethoxyethanol Drugs 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 1
- RNTXYZIABJIFKQ-UHFFFAOYSA-N 4-cyano-4-dodecylsulfanylcarbothioylsulfanylpentanoic acid Chemical compound CCCCCCCCCCCCSC(=S)SC(C)(C#N)CCC(O)=O RNTXYZIABJIFKQ-UHFFFAOYSA-N 0.000 description 1
- 241001468161 Acetobacterium Species 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 description 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241000207155 Heliobacterium Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 241000985694 Polypodiopsida Species 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241001180364 Spirochaetes Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 description 1
- GUCYFKSBFREPBC-UHFFFAOYSA-N [phenyl-(2,4,6-trimethylbenzoyl)phosphoryl]-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C(=O)C1=C(C)C=C(C)C=C1C GUCYFKSBFREPBC-UHFFFAOYSA-N 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 229940050528 albumin Drugs 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- PESYEWKSBIWTAK-UHFFFAOYSA-N cyclopenta-1,3-diene;titanium(2+) Chemical compound [Ti+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 PESYEWKSBIWTAK-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N desyl alcohol Natural products C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229960004132 diethyl ether Drugs 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- KZTYYGOKRVBIMI-UHFFFAOYSA-N diphenyl sulfone Chemical compound C=1C=CC=CC=1S(=O)(=O)C1=CC=CC=C1 KZTYYGOKRVBIMI-UHFFFAOYSA-N 0.000 description 1
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000000755 henicosyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- HDHLIWCXDDZUFH-UHFFFAOYSA-N irgarol 1051 Chemical compound CC(C)(C)NC1=NC(SC)=NC(NC2CC2)=N1 HDHLIWCXDDZUFH-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- PKDBSOOYVOEUQR-UHFFFAOYSA-N mucobromic acid Natural products OC1OC(=O)C(Br)=C1Br PKDBSOOYVOEUQR-UHFFFAOYSA-N 0.000 description 1
- 125000001802 myricyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940112041 peripherally acting muscle relaxants other quaternary ammonium compound in atc Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229940058401 polytetrafluoroethylene Drugs 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- USFMMZYROHDWPJ-UHFFFAOYSA-N trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound CC(=C)C(=O)OCC[N+](C)(C)C USFMMZYROHDWPJ-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0006—Organic membrane manufacture by chemical reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0088—Physical treatment with compounds, e.g. swelling, coating or impregnation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
- B01D69/125—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction
- B01D69/1251—In situ manufacturing by polymerisation, polycondensation, cross-linking or chemical reaction by interfacial polymerisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/56—Polyamides, e.g. polyester-amides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/30—Cross-linking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/34—Use of radiation
- B01D2323/345—UV-treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2323/00—Details relating to membrane preparation
- B01D2323/40—Details relating to membrane preparation in-situ membrane formation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/48—Antimicrobial properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D65/00—Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
- B01D65/08—Prevention of membrane fouling or of concentration polarisation
Definitions
- the present invention relates to a method for the preparation of coated thin-film composite (TFC) membranes on a microporous substrate and their functionalization with polymerizable compounds and optionally additional bio active compounds to yield membranes having antifouling and or anti-bacterial properties.
- Further aspects of the invention are a polymer coating composition on thin-film composite (TFC) membrane, a coated functionalized thin-film composite (TFC) membrane on the microporous substrate itself and the use of such membranes in water purification systems which may be exposed to microbial contamination.
- RO Reverse Osmosis
- Interfacial polymerization is copolymerization of two reactive monomers dissolved in two immiscible solutions respectively.
- the monomers can meet and react only at the interface of the solutions when two solutions are contained in a reaction chamber.
- polymer film is formed at the interface.
- the film is usually very thin because the growing interfacial polymer behaves as a barrier to diffusion of the two monomers, and the polymerization levels off at a limiting thickness, typically of the order of a micrometer or less.
- the interfacial polymerization was frequently carried out at the surface of a microporous substrate, in which case the result is called a thin-film composite membrane. This is for example described by Wamser et al., J. Am. Chem. Soc. 1 1 1 , 1989, 8485-8491 .
- membranes used for sepa- ration purposes like reverse osmosis and/or ultra and micro filtration.
- Membranes may be classified according to their pore dimension in most of the application profiles. For example, in water filtration applications ultra filtration membranes (approximate pore diameter: 100 - 1000 nm) are used for wastewater treatment retaining organic and bioorganic material. Much smaller diameters are required in desalination applications (reverse osmosis; approximate pore diameter 1 nm) for retaining ions.
- the ambient medium is an aqueous phase, where potential blockage may occur by adhesion of microorganisms and bio-film formation.
- a membrane with anti-adhesion properties is desired, which would reduce bio-film formation and thus require less cleaning cycles.
- fouling is currently one of the major remaining problems for aromatic polyamide reverse osmosis (RO) membranes. Fouling causes deterioration of the membrane per- formance and shortens membrane lifetime, limiting further application of RO membrane technology. It is thus desirable to improve antifouling and antibacterial properties to RO membranes without impairing their transport characteristics in order to enhance their resistance.
- RO aromatic polyamide reverse osmosis
- TFC thin-film-composite
- UF/NF ultrafiltration/nanofiltration
- PA polyamide
- the instant invention relates to a method for the preparation of a hydrophilic anti-fouling coating onto commercial RO membranes by UV-induced photo- polymerization of suitable anti-adhesive polymers and monomers.
- further antimicrobial agents may be added to the coating.
- Bacteria contained in the influent water are accumulated by the membranes and consequently accumulate on their surfaces.
- the rapid growth of bacteria results in fouling of the membrane which reduces the flow of water through the membrane and can ad- versely affect the filtering properties of the membrane.
- One aspect of the invention is a method for imparting decreased adhesion of biological material to the surface of a thin-film composite membrane on a microporous substrate by applying a coating comprising the steps
- anti-fouling is used in the context of the present invention as a synonym for the prevention of adhesion of biological material.
- Biological material can be proteins, spores, nucleic acids, viruses or biological cells as well as fragments or extracts of biological cells.
- proteins are fibrous proteins such as actin and tubulin, globular proteins such as albumin, fibrin, thrombin and immunoglobulin, enzymes such as oxidoreduc- tases, transferases and hydrolases, and prions.
- fibrous proteins such as actin and tubulin
- globular proteins such as albumin, fibrin, thrombin and immunoglobulin
- enzymes such as oxidoreduc- tases, transferases and hydrolases, and prions.
- Examples of spores are spores of fungi, ferns and fern allies.
- Examples of nucleic acids are deoxyribonucleic acid and ribonucleic acid.
- viruses are adenovirus, AIDS virus, lambda phage, T4 phage and T7 phage.
- biological cells are archaea, bacterial cells or eukaryotic cells.
- Examples of bacterials cells are cells from the phyla Actinobacteria, Chlamydia, Cya- nobacteria, Firmicutes, Proteobacteria and Spirochaetes.
- Examples of genera of the phylum Actinobacteria are Actinomyces, Arthrobacter, Corynebacterium, Nocardia and Streptomyces.
- Examples of genera of the phylum Firmicutes are Bacillus, Enterococ- cus, Lactobacillus, Lactococcus, Streptococcus, Acetobacterium, Clostridium, Eubac- trium and Heliobacterium.
- Examples of genera of the phylum Proteobacteria are Enter- obacter, Escherichia, Klebsiella, Salmonella, Pseudomonas, Vibrio, Burkholdria, Helicobacter and Campylobacter.
- Cells of the species Escherichia coli are particular pre- ferred bacterial cells.
- Examples of eukaryotic cells are fungal cells, human cells, animal cells and plant cells.
- yeast cells are molds, mushrooms and yeast cells.
- yeast cells are cells of generae Saccharomyces and Candida.
- Cells of the species Saccha- romyces cerevisae and Candida albicans are particular preferred yeast cells.
- the degree of adhesion of biological matter to the surface of a substrate can be determined, for example, by comparing the flux and the retention parameters of the membrane after a period of time.
- the top layer of the thin-film composite membrane is a polyamide layer.
- Polyamides can be polymers formed from at least one monomer having an amide group or an amino as well as a carboxy group or from at least one monomer having two amino groups and at least one monomer having two carboxy groups.
- An example of a monomer having an amide group is caprolactam.
- An example of a diamine is 1 ,6- diaminohexane.
- dicarboxylic acids are adipic acid, terephthalic acid, isophthalic acid and 1 ,4-naphthalenedicarboxylic acid.
- polyamides are polyhexamethylene adipamide and polycaprolactam.
- one or more biocides are additionally added to the coating before exposing it to UV-light.
- biocides are 5-chloro-2-(2,4-dichlorophenoxy)phenol, which is sold, for example, under the tradename Irgasan® DP300, N'-fert-butyl-N-cyclopropyl-6-(methyl- thio)-1 ,3,5-triazine-2,4-diamine, which is sold under the tradename Irgarol® 1051 , 2- thiazol-4-yl-1 H-benzoimidazole, which is sold under the tradename Irgaguard® F3000, chlorhexidine, gallic acid, mucobromic acid, itaconic acid and 3-iodo-2-propynyl butyl carbamate, which is sold under the tradename MaguardTM 1-100.
- Irgasan® DP300 N'-fert-butyl-N-cyclopropyl-6-(methyl- thio)-1 ,3,5-triazine-2,4-diamine
- QA quarternary amines
- zwitterionic methacrylates such as 3-((2- (methacryloyloxy)ethyl) dimethylammonio) propanesulfonate.
- quaternary ammonium compounds carrying one or more ethylenically unsaturat- ed groups are given below. Usually these compounds have biocidal activity.
- the quaternary ammonium compounds carrying one or more ethylenically unsaturated groups can be of formula
- R 58 , R 59 and R 60 can be the same or different and are hydrogen, halogen or Ci-6-alkyl
- R 61 , R 62 and R 63 can be the same or different and are Ci-30-alkyl, C2-3o-alkenyl, C3-8- cycloalkyl, aryl, or R 61 and R 62 together with the N of the ammonium group form a 4 to 8 membered cycle, wherein one CH2 group of the cycle may be replaced with NH or O
- Q and Y can be the same or different and are Ci-15-alkylene
- M is a bridging group
- n and m can be the same or different and are 0 or 1 ,
- J- is an anion, wherein Ci-30-alkyl, C2-3o-alkenyl, C3-8-cycloalkyl or Ci-15-alkylene can be unsubstituted or substituted with one or more aryl, OC2-6-alkenyl, halogen, CN, C(0)OR 64 ,
- Ci-3o-Alkyl can be branched or unbranched.
- Examples of Ci-30-alkyl are methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, fert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, pentadecyl, hexadecyl, octadecyl, eicosyl, heneico- syl, docosyl, tetracosyl and triacontyl.
- Ci-15-alkylene examples include methylene, propylene and butylene.
- bridging groups M are C3-8-cycloalkylene, arylene, polymer, OC(O), C(0)0, NH(CO) and C(0)NH.
- Arylene can be phenylene.
- An example of a polymer is polyethyleneimine.
- J- can be any anion, for example sulfate, sulfite, carbonate, phosphate or halogenide.
- Halogenide can be fluoride, chloride, bromide or iodide.
- Examples of quaternary ammonium compounds carrying one or more ethylenically unsaturated group are trimethylaminoethyl acrylate chloride, trimethylaminoethyl meth- acrylate chloride, trimethylaminotetradecyl acrylate chloride, trimethylaminohexadecyl acrylate chloride, tnmethylaminooctadecyl acrylate chloride and diallyldimethylammo- nium chloride and the compounds of formulae
- More preferred quaternary ammonium compounds carrying one or more ethylenically unsaturated group are of formula
- R 58 , R 59 and R 60 can be the same or different and are hydrogen or Ci-6-alkyl
- R 61 , R 62 and R 63 can be the same or different and are Ci-30-alkyl or C2-3o-alkenyl, Q and Y can be the same or different and are Ci-15-alkylene,
- M is a bridging group selected from the group consisting of arylene, polymer, OC(O) and C(0)0,
- n and m can be the same or different and are 0 or 1 ,
- J- is a halogenide, wherein Ci-30-alkyl, C2-3o-alkenyl or Ci-15-alkylene can be unsubstituted or substituted with one or more OC 2 - 6 -alkenyl, C(0)OR 64 , C(0)NR 65 R 66 , OR 67 , NR 68 R 69 ,
- Most preferred quaternary ammonium compounds carrying one or more ethylenically unsaturated groups are of formula
- R 58 , R 59 and R 60 can be the same or different and are hydrogen or Ci-6-alkyl
- R 61 , R 62 and R 63 can be the same or different and are Ci-30-alkyl
- Q and Y can be the same or different and are Ci-6-alkylene
- M is a bridging group selected from the group consisting of polymer and OC(O), n and m can be the same or different and are 0 or 1 ,
- Examples of Ci-6-alkylene are methylene, propylene and butylene.
- Compounds 3A and 3B are especially preferred quaternary ammonium compounds carrying one or more ethylenically unsaturated groups.
- Compound 3A can be prepared by reacting polyethyleneimine with A/-3-chloro-2- hydroxypropyl-A/-lauryl-dimethylammonium chloride and allyl bromide.
- Compound 3B can be prepared by reacting A/,A/-dimethylaminoethyl methacrylate with dodecyl bromide as described in S.M. Hamid and D.C. Sherrington, Polymer 1987, 28, 325 to 331.
- Inorganic biocides are for example copper, silver and zink, in particular silver in the form of nano-scale silver (as for example described in Water Research, (2008), 42(18), 4591 -4602).
- Silver particles in nano-form have preferably a particle size of 10-100 nm, more preferably 30-80 nm.
- biocides When additional biocides are added to the coating composition they are added in an amount of from 0.1 % to 10% by weight, based on the weight of the partially methacrylated hydroxyl or amine functional polyacrylate, for example, a partially methacrylated polyhydroxyethyl-methacrylate.
- the porous substrate is a polymer selected from the group consisting of a polyester, polysulfone, polycarbonate, polypropylene, polyamide and polyether sulfone.
- Polyolefins such as polypropylene can be polymers formed from at least one olefin monomer or from at least one olefin monomer and maleic monomer.
- poly- olefines are low-density polyethylene (LDPE), high-density polyethylene (HDPE), poly- propylene (PP), biaxially orientated polypropylene (BOPP), polybutadiene, polytetraflu- oroethylene (Teflon-PTFE), chlorinated polyethylene and isopropylene-maleic anhydride copolymer.
- Polyamides can be polymers formed from at least one monomer having an amide group or an amino as well as a carboxy group or from at least one monomer having two amino groups and at least one monomer having two carboxy groups.
- An example of a monomer having an amide group is caprolactam.
- An example of a diamine is 1 ,6- diaminohexane.
- dicarboxylic acids are adipic acid, terephthalic acid, isophthalic acid and 1 ,4-naphthalenedicarboxylic acid.
- polyamides are polyhexamethylene adipamide and polycaprolactam.
- Polyesters can be polymers formed from at least one monomer having a hydroxy as well as a carboxy group or from at least one monomer having two hydroxy groups and at least one monomer having two carboxy groups or a lactone group.
- An example of a monomer having a hydroxy as well as a carboxy group is adipic acid.
- An example of a diol is ethylene glycol.
- An example of a monomer having a lactone group is carprolac- tone.
- dicarboxylic acids are terephthalic acid, isophthalic acid and 1 ,4- naphthalenedicarboxylic acid.
- An example of a polyester is polyethylene terephthalate (PET). So-called alkyd resins are also regarded to belong to polyester polymers.
- polycarbonates are poly(aromatic carbonates) and poly(aliphatic carbonates).
- Poly(aliphatic carbonates) can be formed from carbon dioxide and at least one epoxide.
- sulfone-based polymers are polyarylsulfone, polyethersulfone (PES), poly- phenylsulfone (PPS) and polysulfone (PSF).
- PES polyethersulfone
- PPS poly- phenylsulfone
- PSF polysulfone
- Polysulfone (PSF) is a polymer formed from 4,4-dichlorodiphenyl sulfone and bisphenol A.
- the hydroxyl or amine functional polyacrylate is polyhydroxyethyl-acrylate or polyhydroxyethyl-methacrylate.
- Polyhydroxyethyl-acrylate or polyhydroxyethyl-methacrylate can be obtained according to standard radical polymerization methods using a suitable radical source, such as, for example, azoisobutyronitnle (AI BN) or the like. Both polymers are also commercially available.
- a suitable radical source such as, for example, azoisobutyronitnle (AI BN) or the like. Both polymers are also commercially available.
- the average molecular weight Mw of the hydroxyl or amine functional polyacrylate is from 25 000 to 100 000, preferably 40 000 to 60 000.
- the hydroxyl or amine functional polyacrylate is reacted with methac- ryloylchloride to give a partially methacrylated hydroxyl or amine functional polyacrylate.
- the reaction is well known in the art and can be carried out according to standard procedures. Typically the polymerization above and the polymer analogous reaction are carried out in solution.
- organic solvents are Ci-4-alkanols, C2-4-polyols, C3-6-ketones, C 4 -6-ethers, C2-3-nitriles, nitromethane, dimethylsulfoxide, dimethylformamide, dimethylacetamide, A/-methylpyrolidone and sulfolane, whereby Ci -4 -alkanols and C2- 4 -polyols may be sub- stituted with Ci -4 -alkoxy.
- Ci -4 -alkanols are methanol, ethanol, propanol, isopropanol, butanol, isobutanol, sec-butanol and feri-butanol.
- Ci -4 -alkoxy- derivatives thereof are 2-ethoxyethanol and 1 -methoxy-2-propanol.
- Examples of C2- 4 -polyols are glycol and glycerol.
- Examples of C3-6-ketones are acetone and methyl ethyl ketone.
- Examples of C 4 -6-ethers are dimethoxyethane, diisopropylether and tetra- hydrofurane.
- An example of a C2-3-nitrile is acetonitrile.
- the organic solvent is selected from the group consisting of Ci -4 -alkanols, C2- 4 -polyols, C3-6-ketones, dimethylformamide and dimethylacetamide, whereby Ci -4 -alkanols and C2- 4 -polyols may be substituted with Ci -4 -alkoxy. More preferably, the organic solvent is a Ci -4 -alkanol.
- the degree of methacrylation of the partially methacrylated hydroxyl or amine functional polyacrylate is from 0.1 to 20 mol-%, preferably from 0.5 to 15 mol-% and more preferably from 0.1 to 10 mol-%.
- the weight ratio between the partially methacrylated hydroxyl or amine functional polyacrylate and glycidyl-methacrylate or glycidyl-acrylate is from 200:1 to 50: 1 , preferably 150:1 to 75:1 and more preferably 100: 1 .
- the thin-film composite membrane on a microporous substrate is coated with the partially methacrylated hydroxyl or amine functional polyacrylate and glycidyl-methacrylate or glycidyl-acrylate.
- the coating is applied from a solution of the components to which a photoinitiator is added.
- the solvent may be an organic solvent or a mixture of water with an organic solvent. Examples for suitable organic solvents are outlined above.
- the solvent is a mixture of water and an alcohol, such as ethanol or propanol.
- the ratio between organic solvent and water is from 80:20 to 20:80 by volume, preferably from 80:20 to 40:60.
- the concentration of the components in the solution may be in the range of 1 % to 50%, preferably from 5% to 20% by weight, based on the weight of the total solution.
- the coating may be applied by any coating technique, such as in the form of a draw down with a doctor blade or a spiral coater or by spin coating.
- the wet thick- ness of the coating is in the range of 1 ⁇ to 500 ⁇ , preferably from 10 ⁇ to 100 ⁇ .
- the cured coating layer has a thickness in the range of from 0.1 to 50 ⁇ , preferably, from 1 to 10 ⁇ .
- the exposure to UV light is carried out under inert gas atmosphere.
- inert gases examples include Argon, Xenon, Helium and Nitrogen.
- composition to be coated comprises one or more radical photoinitiators.
- the photoinitiator can be of formula
- L can be hydrogen or
- Ci-6-alkylene can be unsubstituted or substituted with hydroxyl
- R 27 , R 28 and R 29 can be the same or different and can be hydrogen, halogen, hydroxyl, Ci-6-alkyl, aryl, 0-Ci -6 -alkyl, O-aryl, S-Ci -6 -alkyl, S-aryl or NR 30 R 31 , wherein R 30 and R 31 can be the same or different and can be hydrogen or Ci-6-alkyl, or together with the nitrogen form a five to seven membered cycle, wherein a Chb group of the cycle can be replaced with -0-, and Ci-6-alkyl, O-Ci-6-alkyl and S-Ci-6-alkyl can be unsubstituted or substituted with one or more hydroxyl, C2-3o-alkenyl, OC(0)C2-3o- alkenyl or aryl, and X can be
- R 32 , R 35 and R 39 can be the same or different and can be hydrogen, Ci-100-alkyl, C3-8- cycloalkyl, C 2 - 3 o-alkenyl, aryl or C(0)R 44 ,
- R 36 , R 37 and R 38 can be the same or different and can be hydrogen, Ci-100-alkyl, O-C1- 100-alkyl, S-Ci-100-alkyl, NR 45 Ci-ioo-alkyl, Cs-s-cycloalkyl, C 2 - 3 o-alkenyl, aryl or C(0)R 44 , wherein R 45 can have the same meaning as R 32 and R 44 can have the same meaning as R 36 ,
- photoinitiators of formula 2 are benzoin ethers such as benzoin ethyl ether, benzyl monoketals such as 2,2-diethoxy-1 -phenylethanon and 2,2-diethoxy-1 ,2- diphenylethanon, alpha-substituted acetophenone derivatives such as 2-hydroxy-2- methylpropiophenone, 1 -hydroxycyclohexyl phenyl ketone, 2-methyl-4'-(methylthio)-2- morpholino-propiophenone and 2-benzyl-2-(dimethylamino)-4'- morpholinobutyrophenone, acylphosphine oxides such as diphenyl(2,4,6- trimethylbenzoyl)-phosphine oxide or phenylbis(2,4,6-trimethylbenzoyl)-phosphine oxide, alpha-acyloximester such as 1-[4-(phenylthio)phenyl]-2-(0-benzoyl
- R 27 , R 28 and R 29 can be the same or different and are hydrogen, hydroxyl, Ci-6-alkyl, O-Ci-6-alkyl, S-Ci-6-alkyl, S-aryl or NR 30 R 31 , wherein R 30 and R 31 can be the same or different and can be hydrogen or Ci-6-alkyl, or together with the nitrogen form a five to seven membered cycle, wherein a Chb group of the cycle can be replaced with -0-, and Ci-6-alkyl and O-Ci-6-alkyl can be unsubstituted or substituted with one or more hydroxyl, C2-3o-alkenyl or aryl, and
- E and G are -O- or NR 40 , wherein R 40 can be hydrogen or Ci-6-alkyl, or R 40 and R 32 , respectively, R 35 can, together with the nitrogen, form a five to seven membered cycle, wherein a Chb group of the cycle can be replaced with -0-, NH,
- NC(0)C(R 41 )C C(R 42 )R 43 and/or
- R 32 , R 35 and R 39 can be the same or different and are hydrogen, Ci-100-alkyl, C2-30- alkenyl, aryl or C(0)R 44 ;
- R 36 , R 37 and R 38 can be the same or different and are hydrogen, Ci-100-alkyl, O-Ci-100-alkyl or C(0)R 44 ;
- R 33 and R 34 can have the same meaning as R 36 and in addition can, together with the linking carbon atom, form a five to seven membered cycle, R 44 has the same meaning as R 36 ,
- R 41 , R 42 , R 43 , R 52 , R 53 , R 54 , R 55 and R 56 and R 57 can be the same or different and are hydrogen or Ci-6-alkyl, aryl can be unsubstituted or substituted with one or more Ci-4-alkyl, and one or more Chb-groups of Ci-100-alkyl or C2-3o-alkenyl can be replaced with -O- and/or -NR 40 -.
- R 27 , R 28 and R 29 can be the same or different and are hydrogen, hydroxyl, Ci-e-alkyl, O-Ci-6-alkyl, S-Ci-6-alkyl or NR 30 R 31 , wherein R 30 and R 31 can be the same or different and are hydrogen or Ci-6-alkyl; wherein Ci-6- alkyl and O-Ci-6-alkyl can be unsubstituted or substituted with one or more hydroxyl, C2-3o-alkenyl or aryl, and
- R 35 is hydrogen, Ci-100-alkyl or C2-3o-alkenyl, wherein Ci-100-alkyl and C2-3o-alkenyl can be unsubstituted or substituted with one or more amino, hydroxyl,
- R 41 , R 42 , R 43 , R 52 , R 53 and R 54 can be the same or different and are hydrogen or Ci-6-alkyl, and one or more Chb-groups of Ci-100-alkyl or C2-3o-alkenyl can be replaced with -O- and/or -NR 40 -.
- R 27 , R 28 and R 29 are hydrogen or Ci-6- alkyl
- G is -0-;
- R 35 is Ci-100-alkyl, wherein Ci-100-alkyl can be unsubstituted or substi tuted with one or more
- Chb-groups of Ci-100-alkyl can be replaced with -O-
- Especially preferred photoinitiators of formula 2 are diethyleneglycol
- polyethylene glycol (600) di(phenylglyoxylate) is especially preferred.
- the photoinitiator can also be a titanocene or combinations of a benzophenone as well as thioxanthon-derivative with a coinitiator, for example a tertiary amine. But preferably, the photoinitiator is a compound of formula 2.
- the photoinitiators are mostly items of commerce and supplied, for example, by BASF SE.
- the photoinitiators are added in an amount of from 0.1 % to 10% by weight, preferably 0.5% to 5% by weight based on the weight of the partially methacrylated hydroxyl or amine functional polyacrylate, for example, a partially methacrylated polyhydroxyethyl- methacrylate.
- UV lamps suitable for this process are known in the art and commercially availa- ble. Typically medium or high pressure mercury lamps are used. However, it is also possible to use laser light in the UV region.
- a further aspect of the invention is a composition comprising
- composition contains one or more biocides.
- component b) of the above composition is as a cured film on the thin-film composite membrane on a microporous substrate.
- compositions as described above as separating membrane which has antifouling properties in a reverse osmosis process.
- an aspect of the invention is a coated thin-film composite membrane on a mi- croporous substrate obtainable as described above.
- HEMA Hydroxyethyl-methacrylate
- GMA glycidyl-methacrylate
- Methacryloylchloride and silver lactate were purchased from Merck and Fluka, respectively, and used as received. All solvents used were obtained from Merck and were of ACS reagent or HPLC grade.
- Darocur 1 173 photoinitiator was purchased from CIBA (now BASF) and used as received.
- the UV coating experiments were carried out inside a UV cabinet with a power output of the lamp of 10 mW/cm 2 .
- HEMA hydroxyethyl-methacrylate
- AIBN azoisobutyronitrile
- LE membranes (DOW-Filmtec) are washed with water/iso-propanol (70:30 v/v) solvent mixture to remove stabilizers and other impurities from the surface.
- the UV crosslinking is performed in the presence of 1 % GMA (glycidyl-methacrylate), which acts as a surface binder for the polymer coating with or without additional incorporation of antimicrobial silver lactate.
- GMA glycol-methacrylate
- CA Contact Angle
- the contact angle (CA) of dried surfaces is determined by measuring CA of three spots as an average of 6 values after removing first two values when equilibration between a water droplet and the membrane surface is reached. Confidence interval is given for 99% certainty.
- PolyHEMA-MA-1 shows a reduction in flux from initially 160 LMH (for uncoated DOW- LE) to 126 LMH which is still twice the flux of BW-30FR, the commercially available RO membrane with antifouling coating.
- the incorporation of silver has a mixed effect on the flux.
- the flux of PolyHEMA-MA-1 - Ag with 1 % crosslinker concentration it slightly reduced to 98 LMH the flux compared to the silver-free coating (126 LMH).
- the PolyHEMA-MA-10-Ag with 10% crosslinker concentration has the opposite trend with a higher flux compared to the silver-free film (51 vs. 35 LMH). This might suggest that higher cross-linking improve the dispersion of the silver over the coating layer.
- DOW-LE membranes coated with PolyHEMA-MA containing 1 mol% methacrylate units as crosslink- ers are prepared with and without silver lactate.
- the coating thickness is varied by using 24 and 50 ⁇ draw down coater bar.
- the solution concentration of the polymer is 3 wt% in water/i-propanol (70:30 v/v).
- Table 4 shows the results. All the PolyHEMA-MA coated membranes with and without Ag show very similar performance with a reduced initial water flux of around 60 LMH compared to uncoated DOW-LE membranes (87 LMH). This however is higher than BW30 (44 LMH).
- the flux of the fouling solution is very similar between uncoated and coated membranes (-40 LMH) but still higher than BW-30FR. After a gentle rinsing with 30 mL MilliQ water, the recovery of the coated membranes is in the range of 90-100% with PolyHEMA-MA (50 ⁇ ) and PolyHEMA- MA-Ag (24 ⁇ ) showing the best results. This is much higher compared to uncoated DOW-LE, which exhibits only a recovery of -74% supporting the fact that functionaliz- ing RO membrane with these types of coating layer improves membrane anti-fouling properties.
- PolyHEMA samples are stirred in either 0.5wt% HCI or 0.1wt% NaOH aqueous solu- tions for 1 h at 40°C.
- the polymers are afterwards analysed by gel permeation chromatography (GPC) and compared against non-treated PolyHEMA.
- the results show an overall good stability to test this material as anti-adhesive model coating (Table 5).
- Table 5 MWs of PolyHEMA before and after being exposed to cleaning conditions 3
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- Inorganic Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
La présente invention porte sur un procédé pour la préparation de membranes composites à couche mince (TFC) revêtues disposées sur un substrat microporeux et leur fonctionnalisation avec des composés polymérisables et éventuellement des composés bioactifs supplémentaires pour produire des membranes ayant des propriétés antisalissure ou antibactériennes. D'autres aspects de l'invention portent sur une composition de revêtement polymère sur une membrane composite à couche mince (TFC), sur une membrane composite à couche mince (TFC) fonctionnalisée revêtue disposée sur le substrat microporeux elle-même et sur l'utilisation de telles membranes dans des systèmes de purification d'eau qui peuvent être exposés à une contamination microbienne.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261592613P | 2012-01-31 | 2012-01-31 | |
US61/592613 | 2012-01-31 | ||
EP12153214 | 2012-01-31 | ||
EP12153214.7 | 2012-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013114300A1 true WO2013114300A1 (fr) | 2013-08-08 |
Family
ID=48904492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2013/050794 WO2013114300A1 (fr) | 2012-01-31 | 2013-01-30 | Revêtements acryliques modifiés actifs permettant d'obtenir une résistance améliorée de membranes d'osmose inverse à l'encrassement biologique |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR093737A1 (fr) |
WO (1) | WO2013114300A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106861468A (zh) * | 2017-04-19 | 2017-06-20 | 贵州省材料产业技术研究院 | 复合抗污染聚合物分离膜及其制备方法 |
US10569227B2 (en) | 2013-10-15 | 2020-02-25 | Basf Se | Improving the chemical stability of filtration membranes |
CN112870990A (zh) * | 2021-01-11 | 2021-06-01 | 中化(宁波)润沃膜科技有限公司 | 一种抗菌耐污染反渗透复合膜及其制备方法 |
US20220193620A1 (en) * | 2014-12-24 | 2022-06-23 | Hydroxsys Holdings Limited | Asymmetric composite membranes and modified substrates used in their preparation |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112044280B (zh) * | 2019-06-05 | 2022-08-16 | 广州中国科学院先进技术研究所 | 一种抗膜生物污染涂层及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1468649A (zh) * | 2002-07-16 | 2004-01-21 | 世韩工业株式会社 | 耐污染性优良的选择性分离膜的制造方法 |
WO2007127605A2 (fr) * | 2006-04-28 | 2007-11-08 | Dow Global Technologies Inc. | Membrane d'osmose inverse à surface anti-contaminante modifiée par polyoxyde d'alkylène ramifié |
CN101530751A (zh) * | 2009-03-13 | 2009-09-16 | 浙江理工大学 | 一种自清洁型反渗透膜 |
WO2010015599A1 (fr) * | 2008-08-05 | 2010-02-11 | Polymers Crc Limited | Membranes de polyamide à film mince fonctionnalisées |
-
2013
- 2013-01-30 AR ARP130100287A patent/AR093737A1/es not_active Application Discontinuation
- 2013-01-30 WO PCT/IB2013/050794 patent/WO2013114300A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1468649A (zh) * | 2002-07-16 | 2004-01-21 | 世韩工业株式会社 | 耐污染性优良的选择性分离膜的制造方法 |
WO2007127605A2 (fr) * | 2006-04-28 | 2007-11-08 | Dow Global Technologies Inc. | Membrane d'osmose inverse à surface anti-contaminante modifiée par polyoxyde d'alkylène ramifié |
WO2010015599A1 (fr) * | 2008-08-05 | 2010-02-11 | Polymers Crc Limited | Membranes de polyamide à film mince fonctionnalisées |
CN101530751A (zh) * | 2009-03-13 | 2009-09-16 | 浙江理工大学 | 一种自清洁型反渗透膜 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10569227B2 (en) | 2013-10-15 | 2020-02-25 | Basf Se | Improving the chemical stability of filtration membranes |
US20220193620A1 (en) * | 2014-12-24 | 2022-06-23 | Hydroxsys Holdings Limited | Asymmetric composite membranes and modified substrates used in their preparation |
CN106861468A (zh) * | 2017-04-19 | 2017-06-20 | 贵州省材料产业技术研究院 | 复合抗污染聚合物分离膜及其制备方法 |
CN112870990A (zh) * | 2021-01-11 | 2021-06-01 | 中化(宁波)润沃膜科技有限公司 | 一种抗菌耐污染反渗透复合膜及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
AR093737A1 (es) | 2015-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013114297A1 (fr) | Polymérisation uv de monomères acryliques spécifiques sur des membranes d'osmose inverse pour une meilleure résistance aux biosalissures | |
Kochkodan et al. | Polymeric membranes: Surface modification for minimizing (bio) colloidal fouling | |
Jun et al. | Acid-catalyzed hydrolysis of semi-aromatic polyamide NF membrane and its application to water softening and antibiotics enrichment | |
WO2013114300A1 (fr) | Revêtements acryliques modifiés actifs permettant d'obtenir une résistance améliorée de membranes d'osmose inverse à l'encrassement biologique | |
US8528746B2 (en) | Method of manufacturing hydrophilic membrane having improved antifouling property and hydrophilic membrane manufactured by the method | |
Kang et al. | Development of antifouling reverse osmosis membranes for water treatment: A review | |
La et al. | Bifunctional hydrogel coatings for water purification membranes: improved fouling resistance and antimicrobial activity | |
JP5463355B2 (ja) | 改善された汚染耐性を有する浄水膜 | |
Choi et al. | Surface modification of seawater reverse osmosis (SWRO) membrane using methyl methacrylate-hydroxy poly (oxyethylene) methacrylate (MMA-HPOEM) comb-polymer and its performance | |
US20070251883A1 (en) | Reverse Osmosis Membrane with Branched Poly(Alkylene Oxide) Modified Antifouling Surface | |
US10850238B2 (en) | Processes for reducing the fouling of surfaces | |
WO2011005258A1 (fr) | Dépôt de polymère et modification de membranes pour une résistance à l'encrassement | |
Hong Anh Ngo et al. | Surface photochemical graft polymerization of acrylic acid onto polyamide thin film composite membranes | |
JP6022827B2 (ja) | ポリアミド逆浸透膜用の表面処理剤 | |
WO2018181365A1 (fr) | Membrane poreuse, module de membrane, dispositif de traitement d'eau, et procédé de fabrication de membrane poreuse | |
Kim et al. | Preparation and characterization of thermally crosslinked chlorine resistant thin film composite polyamide membranes for reverse osmosis | |
Kim et al. | Polysulfone based ultrafiltration membranes with dopamine and nisin moieties showing antifouling and antimicrobial properties | |
Rahimpour | Preparation and modification of nano-porous polyimide (PI) membranes by UV photo-grafting process: Ultrafiltration and nanofiltration performance | |
JP6464866B2 (ja) | 表面修飾基材、ポリマー被覆基材、およびそれらの製造方法 | |
JP6303837B2 (ja) | 逆浸透膜の耐汚染化処理方法 | |
EP2415515A1 (fr) | Membrane semi-perméable composite et son procédé de fabrication | |
Cheng et al. | Surface modification of ultrafiltration membranes with 1, 4-benzoquinone and polyetheramines to improve fouling resistance | |
JP2011156519A (ja) | 高分子水処理膜、水処理方法及び高分子水処理膜のメンテナンス方法 | |
Nazri et al. | A facile modification approach for polyacrylonitrile-based UF hollow fiber membrane utilizing polyacrylonitrile-g-poly (vinyl alcohol) graft copolymer | |
Liu et al. | PAN ultrafiltration membranes grafted with natural amino acids for improving antifouling property |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13743508 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13743508 Country of ref document: EP Kind code of ref document: A1 |